#1vitalhub Care Evolved Investor presentation NOV 2023 TSX:VHI OTCQX: VHIBF#2Reader's Advisory vitalhub This corporate presentation dated November, 2023 (the "Presentation") has been prepared by management of VitalHub Corp. (the "Corporation"), and is based on public information and the Corporation's confidential information. This Presentation is for information purposes only and is being made available on a confidential basis solely to enable the prospective "accredited" and other qualified investors authorized by the Corporation to evaluate the securities of the Corporation (the "Securities"). This Presentation does not constitute an offer to sell to any person, or a general offer to the public of, or the general solicitation from the public of offers to subscribe or purchase, any of the Securities. Any unauthorized use of this Presentation is strictly prohibited. Distribution or copying of this Presentation, in whole or in part in any medium, to any person other than the prospective investor is prohibited without the prior written consent of the Corporation. The information contained in these slides, the Presentation made to you verbally and any other information provided to you (in writing or otherwise) in connection with the Corporation and its business (the "Presentation Materials") is subject to updating, completion, revision, verification and amendment without notice which may result in material changes. The Presentation Materials are not intended to provide financial, tax, legal or accounting advice and do not purport to contain all the information that a prospective investor may require. Each prospective investor should perform and rely on its own investigation and analysis of the Corporation and the terms of any offering of the Securities, including the merits and risks involved, and are advised to seek their own professional advice on the legal, financial and taxation consequences of making an investment in the Corporation. The Securities are highly speculative. No securities commission or similar regulatory authority in Canada has reviewed or in any way passed upon the Presentation Materials, and any representation to the contrary is an offence. Neither the Corporation nor any agent of the Corporation makes any representation or warranty, express or implied, and assumes no responsibility for the accuracy or completeness of the information contained in the Presentation Materials or any other oral or written communication transmitted to prospective investors, and nothing contained in this summary is, or shall be relied upon as, a promise or representation by the Corporation or any agent of the Corporation as to the past or future performance of the Corporation. The Corporation does not undertake to provide any additional further information or to enter into negotiations regarding the investment opportunity to which these Presentation Materials relate. The Corporation retains the right, at any time, to terminate any discussions or negotiations with prospective investors. In the event of such termination the Corporation will not be under any obligation to disclose the reasons for such termination nor will they have any liability to any recipient hereof for any costs whatsoever incurred in the consideration of the information contained in these Presentation Materials. This presentation contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or "recurring" or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward looking statements contained in this Presentation may include, but are not limited to statements with respect to the successful execution of the Corporation's business strategy (including its business model. M&A strategy and mission), the use and benefits of its products and services, the Corporation's favourable position in the market on a go-forward basis, demographic and market size/trends, forecasts of revenue and financial projections/growth potential/opportunities, the completion of proposed acquisitions of target companies, the use of proceeds from the sale of the Corporation's Securities, competitive analysis, proposed synergies, projected milestones, go-forward management of the Corporation, and other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance, expected regulatory filings, review and approval dates, construction and start-up timelines and schedules, and statements related to the continued overall advancement of the Corporation's projects. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as competition, technological changes, the changing needs of hospitals, the financial condition of VitalHub's current and potential customers, foreign currency exchange rates, as well as general economic conditions, which may cause the actual results, performance or achievements of VitalHub to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this presentation. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The forward looking statements contained in this presentation are made as of the date hereof or the dates specifically referenced in this presentation, where applicable. Except as required by law, the Corporation undertakes no obligation to update publicly or to revise any forward looking statements that are contained or incorporated in this presentation. All forward looking statements contained in this presentation are expressly qualified by this cautionary statement. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this presentation. 2#3Who We Are $ Large, Fragmented Global Market Canada, UK, Australia, Qatar, UAE & Latvia $$$$ Software Consolidator Focused on Health & Human Services Digital Solutions 8-D vitalhub Synergistic M&A Growth Sizable Organic Growth 3#4What We Do vitalhub Efficient Patient Flow & Operational Visibility Patient Flow Solutions ~17 products 60% of revenue Service point journey tools (pre-, during, and post- visit) that increase efficiency, streamline communication and improve quality of care Real Time Operational Visibility Solutions for Providers, Operators and Regulators ~20 products Visibility tools enhancing organizational agility and operational insights, data and analytics Anticipated area for significant future organic growth Optimized EHR, Case Management & Care Coordination 20 modules built on TREAT EHR platform Complete client / medical records accessible by both patients and providers of care Leading vendor in Ontario marketplace, with representation across Canada (Nova Scotia, Yukon Territory, and Northern Ontario) Winning large regional initiatives as single vendor consolidation continues Recently signed multi-year licensing agreement for provincial adult correctional facilities across Ontario Expanding internationally (UK, Australia, Qatar, UAE & Latvia)#5VitalHub Solutions Patient Service-point Journey Create a mobile appointment Join a virtual clinic Appointment Portal SMS Reminders Virtual Clinics ☑ Virtual Clinics vitalhub 30 020210) Patient check in from their car Patient registration at kiosk Patient waits for procedure Procedure performed with activity manager 3 25 Performance management Results are shared in person and online Mobile iReceptionist Walk-In Wayfinding Wayfinding Wait time Activity Manager Performance Manager eOutcomes 5#6Real-Time Operational Visibility VitalHub solutions improve transparency and communication through real-time whole system visibility, Integrated information for coordinated care, and optimization of patient movement HOSPITAL H HOSPITAL HOSPITAL -------- + HOSPITAL H HOSPITAL NOSPIT 1010 T1920 HOSPITAL HOSPITAL#7Vital Hub Solutions - TREAT EHR System vitalhub Registration & Enrolment Integrated care management Billing, reporting and dashboards Facilities Social worker / nurse Client profile creation, scheduling, documentation Doctor Incident reporting, eDocs, Teams & Alerts, Integration and more Administrator, Billing management, Assessment, Reporting, Analytics and more Facilities Facility & Bed Management 7#8Financial Highlights $42.6M $OM Debt ARR vitalhub Strong institution shareholder base $29.8M Cash on-hand Cash flow positive 15% Trailing 12-month organic revenue growth Adjusted EBITDA Positive 14 consecutive quarters 82% Gross profit percentage 8#9Market Size and Opportunity $2.1B marketplace 4 1444 444 -- мил $700 per bed/per year for a VitalHub patient journey product suite Our install base represents 60,000 beds across 4 countries Significant opportunity for organic growth 3 million beds across target regions Canada, Europe, Middle East, Australia Substantial opportunity to sell-in VitalHub's full product suite across existing install base comprising upwards of $20 million#10Innovations Lab 130+ developers, engineers and QA professionals Founded in 2007 100% owned by Vitalhub Broad capabilities supporting over 8 different technology environments Supports development, quality assurance, help desk and Infrastructure 10 10#11M&A Strategy Synergistic rollup strategy with a clearly defined framework for increasing growth and profitability. -S- = Cost-effective R&D The Innovation Lab reduces software development costs Consolidate G&A One central functional area improves efficiencies and effectiveness Sales Cross-selling & upselling VitalHub mHealth platform into install base Optimize S&M Implementation of effective sales and marketing processes Sell Organically Develop and sell new mobile VitalHub products into large growth markets 11#12M&A Model vitalhub 1.0-2.5x Revenue Multiple Median Deal Size Targets owner operators with stable customer base in Canada, UK, Australia plus minimal geographical expansion Combination of cash & stock Annual Revenue $1-12M Breakeven or Profitable 60% Recurring revenue 20-30% Target EBITDA 400 Pipeline of acquisition targets ↓ 20% Reduction in costs for vitalhub 12#13Timeline medworxx An Aptean Company. vitalhub Patient Flow & Operational Visibility EHR, Case Management & Care Coordination vitalhub HInext ROXY software inc. Oculys HEALTH INFORMATICS INC. Transforming Systems JAYEX Acute NECALS BEAUTIFUL INFORMATION Patient Care in Real-Time Web-based EHR (TREAT) SaaS-based Case Management Operational management systems for complex hospital environments Award winning patient flow visibility solutions Provider of integrated SaaS healthcare services delivery platforms, Provider of unique real-time information to NHS trusts COMMUNITY DATA SOLUTIONS Case Management solution for the community sector COYOTE™ SOFTWARE CORPORATION Case Management solutions that streamline the workflows of health and social service organizations Dec 2016 Oct 2017 Jan 2018 Sept 2018 Mar 2019 Nov 2019 Aug 2020 Sept 2020 Apr 2021 May 2021 July 2021 Jan 2022 Apr 2022 Oct 2022 Nov 2022 Jan 2023 Five mental health solutions and offshore Sri Lankan development team Web-based mental health assessments SaaS-based clinical utilization Patient Flow solution B SHARP TECHNOLOGIES INC. CLARITY HEALTH OAK GROUP INTERNATIONAL The Intouch Patient Journey Platform" intouch with health Mobile application that helps mental health professionals efficiently complete Mental Health Act processes ☑S12 Solutions Provider of SaaS- based analytics platform that addresses alamac Provider of healthcare, government, retail, hospitality, law enforcement, manufacturing and commerce solutions Hicom™ A straightforward, adaptable, patient- engagement platform, that puts the patient at the centre of their health care journey ADI #Health ADVANCING HEALTHCARE TECHNOLOGY 10#14Top Line Growth $14.0 $12.0 $10.0 $8.0 38% $6.0 $2.6 52% $3.7 $4.9 39% 36% $3.5 $4.3 38% $5.8 $5.4 43% 44% vitalhub 60% 50% $5.9 45% 40% 30% 20% $4.0 $7.0 $7.2 $7.3 $7.3 $6.3 $5.8 10% $2.0 $4.3 $4.5 0% Q4 2021 Q1_2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Acquisition Organic % organic-revenue 14#15ARR Consistent QoQ Growth ARR has grown organically on average by $1,148K per quarter for the last 8 quarters ARR Quarter on quarter Growth in ARR (%) TSX VHI $24.0 $22.1 $31.2 $31.0 $39.6 $36.1 $41.0 $42.6 vitalhub 0% 9% 30% Q4 2021 Q1 2022 Q2-2022 -1% Q82022 17% Q4-2022 10% Q1-2023 3% 4% Q2 2023 Q8-2023 15#16ARR vitalhub Grown organically on average by over $1,148K for the past eight quarters Annual Recurring Revenue Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 2023 Opening balance ($) 21,569,032 22,106,663 24,015,090 31,219,508 30,967,215 36,145,150 39,634,517 41,008,702 Organic net of churn ($) Organic net of churn (%) 649,416 3% 1,485,613 7% 823,506 3% 850,755 3% 944,110 3% 1,462,766 1,491,003 1,475,976 4% 4% 4% Acquisition ($) Acquisition (%) 0 0% 1,032,000 5% 6,748,747 28% 0 0% 3,000,854 1,100,000 10% 3% 0 0% 0 0% Effect of foreign exchange (loss) gain ($) Effect of foreign exchange (loss) gain (%) (111,785) (1%) (609,186) (3%) (367,835) (2%) (1,103,048) (4%) 1,232,971 4% 926,600 3% (116,818) (0%) 127,489 0% Closing balance ($) 22,106,663 24,015,090 31,219,508 30,967,215 36,145,150 39,634,517 41,008,702 42,612,166 16#17Revenues - last eight quarters vitalhub Term licences, maintenance and support Perpetual licences Services and other Total revenue % Recurring revenues 90% $14.0 $12.0 $10.0 $8.0 $6.0 $4.0 $2.0 TSXVHI Q4 2021 Q1_2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 21 80% 70% 60% 50% 40% 30% 20% 10% 0%#18Revenues and Adjusted EBITDA $14.0 $12.0 $10.0 $8.0 $6.0 $4.0 $2.0 Total revenue Adjusted EBITDA -Adjusted EBITDA Margin % vitalhub 35% 30% 25% 20% 15% 10% 5% 0% Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 TSXVHI 21#19Capitalization Table TSX VHI Basic Shares Outstanding Stock Options & DSUS 43,684,912 3,071,618 Management Control 28% Fully Diluted Shares Outstanding 46,756,530 Net Cash Position 29,794,692 Insider Ownership Enterprise Value (based on a $2.90 share price) Source: Public filings and internal company information as November 8, 2023 2023 Q3_Revenue Q3_AEBITDA 28% $105.80M vitalhub Public Shareholders 72% Quarter ($M) $13.2 Annualized ($M) $52.9 Enterprise Value ($M) $105.8 Multiple 2.0 x $3.4 $13.6 $105.8 7.8 x 19#20Management vitalhub Dan Matlow President & CEO ■ 30 years of experience in technology with a focus on Health IT Previously CEO & Founder at Medworxx Track record of building and growing enterprise software companies Brian Goffenberg, CPA, CA Executive VP & CFO ■ 30 years of experience, multiple CFO roles Previously CFO at Medworxx Vijit Coomara EVP of Development ■ 30 years of experience in Development and Technology Previously CTO & Co-Founder at B Sharp Robert Lazar EVP of Professional Services & Customer Care ■ 28 years of experience Previously CEO & Co-Founder at B Sharp Mike Sanders CEO of VitalHub UK Group 20 years of experience in Healthcare Operations Management Previously COO UK & Ireland of Intouch with Health. Niels Tofting EVP of Business Development & Marketing ■ 20 years of software experience Previously VP Sales at Logibec 20#21Board of Directors vitalhub Dan Matlow - 30 years experience in technology field with focus on Health IT ■ Track record of building and growing enterprise software companies Strong sales, marketing, and investor relations skills ■ Proven ability to scale businesses and grow internationally Deep knowledge of the Healthcare IT marketplace Francis Shen ■ President of Shen Capital Corporation Former Chairman, Co-Chief Executive Officer and founder of Aastra Technologies Ltd. ■ He holds a Master and Bachelor of Applied Science both from the University of Toronto. ■ Mr. Shen is a board member of the Toronto General & Western Hospital Foundation, the Toronto International Film Festival, the ROM Board of Governors and NEXT Canada. He is also the co-chair of the Entrepreneurship Leadership Council, and the founder and sponsor of Start@UTIAS at the University of Toronto. Chris Schnarr ■ Mr. Schnarr has a combined 25 years of public company Board experience across NYSE, TSX and TSX Venture Exchange listed companies, as well as extensive audit and compensation committee experience. ■ Mr. Schnarr also serves on the Board of Directors of BioSteel Sports Nutrition Inc., Popreach Corporation (TSXV:POPR) and Stormcrow Holdings Corp. ■ He is a member of the Institute of Corporate Directors, a graduate of the Directors Education Program at the Rotman School of Business at the University of Toronto and holds the ICD.D designation. Roger Dent ■ Chief Executive and Director of Quinsam Capital Corporation ■ Former Portfolio Manager with Matrix Fund Management and Director of Research for CIBC World Markets ■ Mr. Dent is a director of AcuityAds Holdings Inc., Omni-Lite Industries Canada, Inc., Deveron UAS Corp., and California Nanotechnologies Corp. ■ He holds a Master of Business Administration from Harvard Business School and a Bachelor of Commerce from Queen's University. Barry Tissenbaum Retired former Senior Partner with Ernst & Young Currently serves on the Noranda Income Fund Board, and is Chairman of the Audit Committee Mr. Tissenbaum obtained his Chartered Accountant designation in Quebec in 1968 and in Ontario in 1974. He is a member of the Canadian Institute of Chartered Accountant and the Institute of Chartered Accountant of Ontario. Steve Garrington Former Executive Vice President InterSystems Inc. Based in Sydney Australia, Steve Garrington is a graduate of the Australian Institute of Directors (GAICD) ■ Mr. Garrington has previously served on public company boards in the UK, Australia and Canada, and has held leadership positions at several international software companies including; Misys, Torex, Ascribe, IBA Health, iSOFT and InterSystems. Tony Shen ■ Former Co-Chief Executive Officer, President and Chief Operating Officer at Aastra Technologies Limited. ■ He holds a Bachelor of Applied Science (Engineering Physics) from the University of Toronto. ■ He served on the board of Astra Technologies from 1996 to 2104 and subsequently, of Mital Networks Corporation until 2015. 21#22Why Invest Compelling High-margin End-to-end Strong, Positive EBITDA & Solutions Growing ARR Generating Strong Recurring Revenue vitalhub Accreditive M&A Yields High-Value Suite Of Synergistic Solutions Leading Hospital, Community Agency & Mental Health Customers Sizable & Fragmented Global Market Achieving Organic Growth Cost-effective R&D through The Innovations Lab, Increases Margins & Synergized Solutions 1 2 3 4 5 6 22 22#23vitalhub Care Evolved Dan Matlow, President & CEO [email protected] Brian Goffenberg, CFO & EVP [email protected] Daniel Kim, Corporate Development [email protected]